Global 25G Transconjunctival Sutureless Vitrectomy System Market Growth 2026-2032
Description
The global 25G Transconjunctival Sutureless Vitrectomy System market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
United States market for 25G Transconjunctival Sutureless Vitrectomy System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for 25G Transconjunctival Sutureless Vitrectomy System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for 25G Transconjunctival Sutureless Vitrectomy System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key 25G Transconjunctival Sutureless Vitrectomy System players cover Alcon, Bausch + Lomb, Dutch Ophthalmic Research Center, NIDEK, Suzhou Synergy Medical Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “25G Transconjunctival Sutureless Vitrectomy System Industry Forecast” looks at past sales and reviews total world 25G Transconjunctival Sutureless Vitrectomy System sales in 2025, providing a comprehensive analysis by region and market sector of projected 25G Transconjunctival Sutureless Vitrectomy System sales for 2026 through 2032. With 25G Transconjunctival Sutureless Vitrectomy System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 25G Transconjunctival Sutureless Vitrectomy System industry.
This Insight Report provides a comprehensive analysis of the global 25G Transconjunctival Sutureless Vitrectomy System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 25G Transconjunctival Sutureless Vitrectomy System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 25G Transconjunctival Sutureless Vitrectomy System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 25G Transconjunctival Sutureless Vitrectomy System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 25G Transconjunctival Sutureless Vitrectomy System.
This report presents a comprehensive overview, market shares, and growth opportunities of 25G Transconjunctival Sutureless Vitrectomy System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Standard
Combination
Segmentation by Application:
Ophthalmology
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Alcon
Bausch + Lomb
Dutch Ophthalmic Research Center
NIDEK
Suzhou Synergy Medical Technology
Shanghai Fosun Pharmaceutical Group
Beijing Kangruide Medical Technology
Shanghai New Vision Ophthalmic Equipment
Shenzhen Ophthalmic Equipment
Key Questions Addressed in this Report
What is the 10-year outlook for the global 25G Transconjunctival Sutureless Vitrectomy System market?
What factors are driving 25G Transconjunctival Sutureless Vitrectomy System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 25G Transconjunctival Sutureless Vitrectomy System market opportunities vary by end market size?
How does 25G Transconjunctival Sutureless Vitrectomy System break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
United States market for 25G Transconjunctival Sutureless Vitrectomy System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for 25G Transconjunctival Sutureless Vitrectomy System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for 25G Transconjunctival Sutureless Vitrectomy System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key 25G Transconjunctival Sutureless Vitrectomy System players cover Alcon, Bausch + Lomb, Dutch Ophthalmic Research Center, NIDEK, Suzhou Synergy Medical Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “25G Transconjunctival Sutureless Vitrectomy System Industry Forecast” looks at past sales and reviews total world 25G Transconjunctival Sutureless Vitrectomy System sales in 2025, providing a comprehensive analysis by region and market sector of projected 25G Transconjunctival Sutureless Vitrectomy System sales for 2026 through 2032. With 25G Transconjunctival Sutureless Vitrectomy System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 25G Transconjunctival Sutureless Vitrectomy System industry.
This Insight Report provides a comprehensive analysis of the global 25G Transconjunctival Sutureless Vitrectomy System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 25G Transconjunctival Sutureless Vitrectomy System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 25G Transconjunctival Sutureless Vitrectomy System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 25G Transconjunctival Sutureless Vitrectomy System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 25G Transconjunctival Sutureless Vitrectomy System.
This report presents a comprehensive overview, market shares, and growth opportunities of 25G Transconjunctival Sutureless Vitrectomy System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Standard
Combination
Segmentation by Application:
Ophthalmology
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Alcon
Bausch + Lomb
Dutch Ophthalmic Research Center
NIDEK
Suzhou Synergy Medical Technology
Shanghai Fosun Pharmaceutical Group
Beijing Kangruide Medical Technology
Shanghai New Vision Ophthalmic Equipment
Shenzhen Ophthalmic Equipment
Key Questions Addressed in this Report
What is the 10-year outlook for the global 25G Transconjunctival Sutureless Vitrectomy System market?
What factors are driving 25G Transconjunctival Sutureless Vitrectomy System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 25G Transconjunctival Sutureless Vitrectomy System market opportunities vary by end market size?
How does 25G Transconjunctival Sutureless Vitrectomy System break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
101 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for 25G Transconjunctival Sutureless Vitrectomy System by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for 25G Transconjunctival Sutureless Vitrectomy System by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
